Advancements in Insulin Drug and Delivery Technologies: A Focus on Syringes and Vials with BCC Research Analysis
"According to the latest BCC Research study, the demand for Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials is estimated to increase from $55.8 billion in 2023 to reach $88.9 billion by 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028."
United States Cardinal Health North America Global Markets Emerging Insulin Drug Delivery Technologies Focus
Source: yahoo.com